Citation: Gb. Kristensen et al., Mineralization of 2,4-D, mecoprop, isoproturon and terbuthylazine in a chalk aquifer, PEST MAN SC, 57(6), 2001, pp. 531-536
Authors:
Davidson, B
Goldberg, I
Berner, A
Nesland, JM
Givant-Horwitz, V
Byrne, M
Risberg, B
Kristensen, GB
Trope, CG
Kopolovic, J
Reich, R
Citation: B. Davidson et al., Expression of membrane-type 1, 2, and 3 matrix metalloproteinases messenger RNA in ovarian carcinoma cells in serous effusions, AM J CLIN P, 115(4), 2001, pp. 517-524
Authors:
Davidson, B
Lazarovici, P
Ezersky, A
Nesland, JM
Berner, A
Risberg, B
Trope, CG
Kristensen, GB
Goscinski, M
van de Putte, G
Reich, R
Citation: B. Davidson et al., Expression levels of the nerve growth factor receptors TrkA and p75 in effusions and solid tumors of serous ovarian carcinoma patients, CLIN CANC R, 7(11), 2001, pp. 3457-3464
Authors:
Davidson, B
Reich, R
Berner, A
Givant-Horwitz, V
Goldberg, I
Risberg, B
Kristensen, GB
Trope, CG
Bryne, M
Kopolovic, J
Nesland, JM
Citation: B. Davidson et al., Ovarian carcinoma cells in serous effusions show altered MMP-2 and TIMP-2 mRNA levels, EUR J CANC, 37(16), 2001, pp. 2040-2049
Authors:
Baekelandt, M
Lehne, G
Trope, CG
Szanto, I
Pfeiffer, P
Gustavssson, B
Kristensen, GB
Citation: M. Baekelandt et al., Phase I/II trial of the multidrug-resistance modulator valspodar combined with cisplatin and doxorubicin in refractory ovarian cancer, J CL ONCOL, 19(12), 2001, pp. 2983-2993
Authors:
Davidson, B
Risberg, B
Goldberg, I
Nesland, JM
Berner, A
Trope, CG
Kristensen, GB
Bryne, M
Reich, R
Citation: B. Davidson et al., Ets-1 mRNA expression in effusions of serous ovarian carcinoma patients isa marker of poor outcome, AM J SURG P, 25(12), 2001, pp. 1493-1500
Authors:
Davidson, B
Risberg, B
Berner, A
Nesland, JM
Trope, CG
Kristensen, GB
Bryne, M
Goscinski, M
de Putte, GV
Florenes, VA
Citation: B. Davidson et al., Expression of cell cycle proteins in ovarian carcinoma cells in serous effusions-biological and prognostic implications, GYNECOL ONC, 83(2), 2001, pp. 249-256
Authors:
Alfsen, GC
Kristensen, GB
Skovlund, E
Pettersen, EO
Abeler, VM
Citation: Gc. Alfsen et al., Histologic subtype has minor importance for overall survival in patients with adenocarcinoma of the uterine cervix - A population-based study of prognostic factors in 505 patients with nonsquamous cell carcinomas of the cervix, CANCER, 92(9), 2001, pp. 2471-2483
Authors:
Vergote, I
Rustin, GJS
Eisenhauer, EA
Kristensen, GB
Pujade-Lauraine, E
Parmar, MKB
Friedlander, M
Jakobsen, A
Vermorken, JB
Citation: I. Vergote et al., Re: New guidelines to evaluate the response to treatment in solid tumors [ovarian cancer], J NAT CANC, 92(18), 2000, pp. 1534-1535
Authors:
Baekelandt, M
Holm, R
Nesland, JM
Trope, CG
Kristensen, GB
Citation: M. Baekelandt et al., Expression of apoptosis-related proteins is an independent determinant of patient prognosis in advanced ovarian cancer, J CL ONCOL, 18(22), 2000, pp. 3775-3781
Authors:
Berner, HS
Davidson, B
Berner, A
Risberg, B
Kristensen, GB
Trope, CG
Van de Putte, G
Nesland, JM
Citation: Hs. Berner et al., Expression of CD44 in effusions of patients diagnosed with serous ovarian carcinoma - diagnostic and prognostic implications, CLIN EXP M, 18(2), 2000, pp. 197-202
Authors:
Baekelandt, MM
Holm, R
Nesland, JM
Trope, CG
Kristensen, GB
Citation: Mm. Baekelandt et al., P-glycoprotein expression is a marker for chemotherapy resistance and prognosis in advanced ovarian cancer, ANTICANC R, 20(2B), 2000, pp. 1061-1067
Authors:
Davidson, B
Berner, A
Nesland, JM
Risberg, B
Kristensen, GB
Trope, CG
Bryne, M
Citation: B. Davidson et al., Carbohydrate antigen expression in primary tumors, metastatic lesions, andserous effusions from patients diagnosed with epithelial ovarian carcinoma: Evidence of up-regulated Tn and Sialyl Tn antigen expression in effusions, HUMAN PATH, 31(9), 2000, pp. 1081-1087
Authors:
Davidson, B
Berner, A
Nesland, JM
Risberg, B
Berner, HS
Trope, CG
Kristensen, GB
Bryne, M
Florenes, VA
Citation: B. Davidson et al., E-cadherin and alpha-, beta-, and gamma-catenin protein expression is up-regulated in ovarian carcinoma cells in serous effusions, J PATHOLOGY, 192(4), 2000, pp. 460-469
Authors:
Helland, A
Kraggerud, SM
Kristensen, GB
Holm, R
Abeler, VM
Huebner, K
Borresen-Dale, AL
Lothe, RA
Citation: A. Helland et al., Primary cervical carcinomas show 2 common regions of deletion at 3P, 1 within the FHIT gene: Evaluation of allelic imbalance at FHIT, RB1 and TP53 inrelation to survival, INT J CANC, 88(2), 2000, pp. 217-222
Authors:
Alfsen, GC
Thoresen, SO
Kristensen, GB
Skovlund, E
Abeler, VM
Citation: Gc. Alfsen et al., Histopathologic subtyping of cervical adenocarcinoma reveals increasing incidence rates of endometrioid tumors in all age groups - A population basedstudy with review of all nonsquamous cervical carcinomas in Norway from 1966 to 1970, 1976 to 1980, and 1986 to 1990, CANCER, 89(6), 2000, pp. 1291-1299
Authors:
Baekelandt, M
Nesbakken, AJ
Kristensen, GB
Trope, CG
Abeler, VM
Citation: M. Baekelandt et al., Carcinoma of the fallopian tube - Clinicopathologic study of 151 patients treated at the Norwegian Radium Hospital, CANCER, 89(10), 2000, pp. 2076-2084
Authors:
Baekelandt, M
Holm, R
Trope, CG
Nesland, JM
Kristensen, GB
Citation: M. Baekelandt et al., Lack of independent prognostic significance of p21 and p27 expression in advanced ovarian cancer: An immunohistochemical study, CLIN CANC R, 5(10), 1999, pp. 2848-2853
Authors:
Baekelandt, M
Holm, R
Trope, CG
Nesland, JM
Kristensen, GB
Citation: M. Baekelandt et al., The significance of metastasis-related factors cathepsin-D and nm23 in advanced ovarian cancer, ANN ONCOL, 10(11), 1999, pp. 1335-1341
Authors:
Baekelandt, M
Kristensen, GB
Nesland, JM
Trope, CG
Holm, R
Citation: M. Baekelandt et al., Clinical significance of apoptosis-related factors p53, Mdm2, and Bcl-2 inadvanced ovarian cancer, J CL ONCOL, 17(7), 1999, pp. 2061-2068
Authors:
Baekelandt, M
Kristensen, GB
Trope, CG
Nesland, JM
Holm, R
Citation: M. Baekelandt et al., Epidermal growth factor receptor expression has no independent prognostic significance in advanced ovarian cancer, ANTICANC R, 19(5C), 1999, pp. 4469-4474